Novel xanthine oxidase inhibitors as a therapeutic agent or a preventive agent for gout and hyperuricemia

被引：0
|
作者：
Kawana, Asahi [1 ]
Kanazawa, Chikashi [1 ]
Takahashi, Yoshimasa [1 ]
Muroga, Yumiko [1 ]
Imazeki, Mariko [1 ]
Nakada, Yoshio [1 ]
机构：
[1] Teijin Pharma Ltd, Hino, Tokyo, Japan
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2015年 / 250卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
139
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Discovery of a Potent and Orally Bioavailable Xanthine Oxidase/Urate Transporter 1 Dual Inhibitor as a Potential Treatment for Hyperuricemia and Gout
    Yang, Xinye
    Li, Yong
    Pan, Shengqiang
    Ma, Facheng
    Chen, Hong
    Deng, Jinhui
    Yue, Jie
    Gong, Qijie
    Zheng, Mi
    Zeng, Ying
    Li, Jing
    Zhang, Yingjun
    Wang, Xiaojun
    Zhang, Xiaojin
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (16) : 14668 - 14691
  • [42] Pharmacokinetics and pharmacodynamics of febuxostat (TMX-67), a non-purine selective inhibitor of xanthine oxidase/xanthine dehydrogenase (NPSIXO) in patients with gout and/or hyperuricemia
    Komoriya, K
    Hoshide, S
    Takeda, K
    Kobayashi, H
    Kubo, J
    Tsuchimoto, M
    Nakachi, T
    Yamanaka, H
    Kamatani, N
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2004, 23 (8-9): : 1119 - 1122
  • [43] Effects of Xanthine Oxidase Inhibitors on Cardiovascular Disease in Patients with Gout: Ascertaining the Efficacy of Treatment Matters
    Andres, Mariano
    Sivera, Francisca
    Pascual, Eliseo
    AMERICAN JOURNAL OF MEDICINE, 2015, 128 (09): : E41 - E42
  • [44] Integrin Inhibitors as a Therapeutic Agent for Ovarian Cancer
    Sawada, Kenjiro
    Ohyagi-Hara, Chifumi
    Kimura, Tadashi
    Morishige, Ken-ichirou
    JOURNAL OF ONCOLOGY, 2012, 2012
  • [45] Xanthine oxidase inhibitors may prevent or slow chronic kidney disease even in the absence of hyperuricemia Reply
    Panchapakesan, Usha
    Pollock, Carol
    KIDNEY INTERNATIONAL, 2018, 94 (04) : 831 - 831
  • [46] Therapeutic importance of astilbin for the treatment of renal injury and hyperuricemia: Biological importance of xanthine oxidase in the kidney disorders
    Patel, D. K.
    Patel, K.
    CLINICA CHIMICA ACTA, 2022, 530 : S52 - S52
  • [47] STANOZOLOL AS A NOVEL THERAPEUTIC AGENT IN DERMATOLOGY
    HELFMAN, T
    FALANGA, V
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1995, 33 (02) : 254 - 258
  • [48] A novel NLRP3 inhibitor as a therapeutic agent against monosodium urate-induced gout
    Park, Kihyoun
    Shin, Injae
    Kim, Yoonseon
    Kang, Hyereen
    Oh, Soo-Jin
    Jang, Eunkyeong
    Sim, Taebo
    Youn, Jeehee
    Lee, Myung-Shik
    FRONTIERS IN IMMUNOLOGY, 2024, 14
  • [49] CLINICAL TESTING OF A MULTIPLE THERAPEUTIC AGENT CARIES PREVENTIVE PROGRAM
    DOWNER, MC
    HOLLOWAY, PJ
    DAVIES, TGH
    JOURNAL OF DENTAL RESEARCH, 1975, 54 : L76 - L76
  • [50] The magic and mystery of statins in aging: The potent preventive and therapeutic agent
    Hu, Heng-Jing
    Zhou, Sheng-Hua
    Liu, Qi-Ming
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 187 : 58 - 59
12345